Home › Pancreatic Cancer › NCT02012699
Integrated Cancer Repository for Cancer Research
Who can join
Ages 19 to 110 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria * Diagnosis/history of cancer * Risk for developing cancer or suspicious clinical findings * No history of cancer (normal control registry) * Able to provide informed consent * 19 years of age or older * English or Spanish speaking individuals Exclusion Criteria * Unable to provide informed consent because of cognitive impairment * Non-English or non-Spanish speaking individuals
About the study
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.
Sponsor: University of Nebraska · Participants: 999,999 · Started: Nov 1, 2013
Contact the study team
- Artem Pachikov · Phone: 402-559-0568
Official record on ClinicalTrials.gov — NCT02012699
Locations in the U.S.
Conditions
- Pancreatic Cancer
- Thyroid Cancer
- Lung Cancer
- Esophageal Cancer
- Colon Cancer
- Rectal Cancer
- Gastrointestinal Stromal Tumors
- Anal Cancer
- Bile Duct Cancer
- Intestinal Cancer
- Gallbladder Cancer
- Stomach Cancer
- Liver Cancer
- Ovarian Cancer
- Adenomatous Polyposis Coli
- Hereditary Nonpolyposis Colorectal Cancer
- Bladder Cancer
- Kidney Cancer
- Penile Cancer
- Prostate Cancer
- Testicular Cancer
- Ureteral Cancer
- Urethral Cancer
- Hypopharyngeal Cancer
- Laryngeal Cancer
- Oral Cancer
- Nasopharyngeal Cancer
- Oropharyngeal Cancer
- Salivary Gland Cancer
- Skin Cancer
- Brain and Spinal Cord Tumors
- Mesothelioma
- Breast Cancer
- Leukemia
- Melanoma
- Soft Tissue Sarcoma
- Unknown Primary Cancer
- Multiple Myeloma
- Endometrial Cancer
- Vaginal Cancer
- Neuroendocrine Tumors
- Paraproteinemias
- Thyroid Nodule
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.